Antibacterial Activity of Alchornea cordifolia (Christmas bush) Leaves Extract on Carbapenem Resistant Enterobacteriaceae Causing Multi-drug Resistant Systemic Infections by Hackman, Henry Kwadwo et al.
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online)  
Vol.10, No.10, 2020 
 
14 
Antibacterial Activity of Alchornea cordifolia (Christmas bush) 
Leaves Extract on Carbapenem Resistant Enterobacteriaceae 
Causing Multi-drug Resistant Systemic Infections 
 
Henry Kwadwo Hackman1*      Reuben Essel Arhin2      Bright Kojo Azumah2 
David Boateng2      Blessing Nwosu2      Mark Appenteng3 
1.Accra Technical University, Faculty of Applied Sciences 
Department of Medical Laboratory Technology, P. O. Box GP 561, Accra, Ghana 
2.Accra Technical University, Faculty of Applied Sciences 
Department of Science Laboratory Technology, P. O. Box GP 561, Accra, Ghana 
3.Centre for Plant Medicine Research (CPMR), Mampong-Akuapim, Ghana 
 
Abstract 
Carbapenems have been used for the treatment of systemic infections caused by Enterobacteriaceae. However, 
recent studies suggested that some Enterobacteriaceae are producing carbapenemases, which has limited the 
treatment options for carbapenem-resistant Enterobacteriaceae. Some of the emerging carbapenemase resistant 
Enterobacteriaeae that are causing multi-drug resistant systemic infections include Escherichia coli, Klebsiellae 
pneumoniae, Providencia rettgeri, Proteus mirabili, Pantoea species, Citrobacter koseri and Acinetobacter 
baumanii. There is therefore the need for alternative treatment regimens for carbapenem-resistant 
Enterobacteriaceae. This study determined the in vitro efficacy of Alchornea cordifolia on carbapenem-resistant 
Enterobacteriaceae using agar well diffusion and well microplate dilution method. Serial dilutions of the ethanolic 
crude extract of the leaves were prepared and used against the carbapenem-resistant Enterobacteriaceae. The 
phytochemical screening was also performed to determine the antibacterial compounds. The christmas bush leaves 
extracts concentrations ranging from 50 mg/ml – 200 mg/ml showed active diameter zone of inhibition. The 
ethanolic extract of Christmas bush leaves had minimum inhibition concentration and minimum bactericidal 
concentration of 3.13mg/ml indicating significant antibiotic activity against the carbapenem-resistant 
Enterobacteriaceae. The phytochemical screening of the Christmas bush leaves showed the presence of 
antimicrobial phytochemicals such as flavonoids. This offers the possibility of developing effective antimicrobial 
agent to treat multi-drug resistant systemic infections. Therefore, there is the need to determine the toxicological 
effect and perform clinical trials of the active antimicrobial compounds isolated in the leave extracts of Christmas 
bush shrub.  
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1.0 Introduction 
Enterobacteriaceae are inhabitants of the intestinal flora and are the source of community and hospital acquired 
systemic infections. They have the propensity to spread easily between humans (hand carriage, contaminated food 
and water) and to acquire genetic material through horizontal gene transfer, mediated mostly by plasmids and 
transposons (Nordmann et al, 2011). Since 2000, spread of community acquired enterobacterial isolates that 
produce extended-spectrum β-lactamases (ESBLs) capable of hydrolyzing almost all cephalosporins except 
carbapenems has been reported worldwide (Pitout and Laupland, 2008).  
There are strains of Enterobacteriaceae that can produce carbapenemase, an enzyme capable of destroying 
carbapenem antibiotics. Some of the emerging carbapenemase resistant Enterobacteriaeae (CRE) responsible for 
systemic infections include Escherichia coli, Klebsiellae pneumonia, Providencia rettgeri, Proteus mirabili, 
Pantoea species, Citrobacter koseri and Acinetobacter baumanii (Hackman et al., 2017). Systemic bacterial 
infections affect almost all part of the human body systems causing infections such as sepsis, pneumonia, 
peritonitis, gastroenteritis, meningitis and urinary tract infections.                                                  
Carbapenems are a valuable family of antibiotics normally reserved for serious systemic infections caused by 
drug resistant Gram-negative bacteria (including Enterobacteriaceae). They include meropenem, ertapenem, 
imipenem and doripenem. The presence of carbapenamase makes Enterobacteriaceae resistant to multiple 
antimicrobials and therefore infections caused by CPE (Carbapenamase producing Enterobacteriaceae) limit 
treatment options. The first carbapenemase producer in Enterobacteriaceae (NmcA) was identified in 1993 (Naas 
and Nordmann, 1994). Since then, a large variety of carbapenemases has been identified in Enterobacteriaceae 
belonging to 3 classes of β-lactamases (Queenan and Bush, 2007). 
One of the major public health challenges in the 21st century is the increasing dominance of antibiotic 
resistant strains in most bacterial infections. Antibiotic resistance in bacteria may be an inherent character of the 
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organism that renders it naturally non-susceptible to specific antibiotics. The misuse of antibiotics in humans and 
animals is accelerating the process of antibiotic resistance development. When antibiotics are misused or over 
prescribed, bacteria become resistant to their effects, making some infectious diseases difficult to treat.  
Previous studies by Hackman et al., 2013 in Accra established that extended-spectrum beta-lactamase (ESBL) 
producers were increasingly becoming a public health nuisance due to community acquired and nosocomial 
infections. Since ESBL producers resulted in multi-drug resistance among most beta-lactams and non-beta-lactams, 
carbapenems such as imipenem, meropenem and ertapenems are often the last resort for the treatment of ESBL 
infections (Hackman et al., 2017). Until recently, carbapenems have been successfully used for the treatment of 
infections caused by Enterobacteriaceae, including those producing extended-spectrum beta-lactamases 
(Vardakas et al., 2012). However, carbapenemases confer resistance to broad-spectrum antibiotics, usually 
including carbapenems, and therefore, the majority of carbapenemase-producing Enterobacteriaceae are 
carbapenem resistant (CRE).  
Antibiotic treatment options for these multidrug-resistant infections are limited (Falagas et al., 2013). The 
screening of natural products has been the source of innumerable therapeutic agents (Korosecchviz  and Howe-
Grant, 1992). Higher plants, as a source for new potential drugs is still largely unexplored and only a small 
percentage of them has been subjected to phytochemical investigation and the fractions submitted to 
pharmacological screening is very low (Saraswathy et al., 2011).  
The leaves, stems and roots of Alchornea cordifolia (Schumach. and Thonn.) Müll. Arg. are used as 
traditional medicine in many African countries for the management of gastrointestinal, respiratory and urinary 
tract infections as well as for the treatment of wounds (Siwe Noundou et al., 2016).  
According to George et al., (2010), the potency of the A. cordifolia leaves extract could be attributed to 
various classes of compounds such as steroids, tri-terpenoids, phenols and polyphenols, alkaloids, flavonoids, an- 
thraquinones, saponins and tannins, already known to be present in A. cordifolia leaves.  
Siwe Noundou et al. (2016) isolated seven compounds from A. cordifolia with antibacterial activities namely  
stigmasterol, stigmasta-4,22-dien-3-one, friedelin, friedelane-3-one-28-al, 3-O-acetyl-aleuritolic acid , 3-O-
acetyl-erythrodiol and methyl-3,4,5-trihydroxybenzoate (methyl gallate). 
In this study, the antibacterial activity of ethanolic extract of the leaves of A. cordifolia was tested against 
carbapenem-resistant enterobacteriaceae by determining its minimum inhibition concentration, minimum 
bactericidal concentration and percentage inhibition concentration of A. cordifolia extract. The study was based 
on the hypothesis that A. cordifolia will possess phytochemical compounds that will have antimicrobial properties 
against Carbapenem-resistant enterobacteraeceae through in vitro analysis. 
 
2.0 Methods 
2.1 Study Site 
This research work was carried out at the Centre for Plant Medicine Research, Mampong-Akuapem in the Eastern 
Region of Ghana.  
 
2.2 Sampling of Test Plant Material and Extracts Preparation  
Thousand gram (1000g) of the plant leaves were collected and authenticated at the herbarium at the Centre for 
Plant Medicine Research (CPMR), Mampong-Akuapem. The sampling was based on the assumption that the plant 
is healthy and uninfected. The plant parts were cut into pieces, air dried at 26 ± 2oC for ten days and milled into 
coarse powder with the aid of an electric blender.  
 
2.3 Ethanolic Extraction, Evaporation and Freeze Drying of Extracts 
Three hundred grams (300g) of the powdered plant part was soaked in 2L of  96% absolute ethanol for 72 hours 
with occasional stirring and was filtered through Wathman’s No.1 filter paper. The filtrate was concentrated with 
the aid of a rotary evaporator and was freeze-dried using the freeze drying machine at a temperature and reduced 
pressure of 35°C and 100-80hPa respectively. The dried extract was stored under refrigeration condition (4oC) 
until needed. 
 
2.4 Reconstitution of Serial Concentrations of the Crude Extract 
Eight hundred milligrams (800mg) of the dried crude extracts were disolved in 4ml of 5% v/v dimethyl sulphoxide 
(DMSO) to prepare 200mg/ml concentration of the leaves extract. Subsequent concentrations of 100, 50, 25, and 
12.5 mg/ml were achieved using the conventional two folds dilution technique. 
 
2.5 Preparation of Muellar Hinton Agar (MHA) as a Culture Media 
The culture media were prepared according to the manufacturers instruction. Thirty eight grams (38g) of the 
powder was suspended in 1000 ml of demineralized water and heated to boil with agitation to completely dissolve 
the powder. The medium was then sterilized by autoclaving at 121 ºC for 15 minutes. 
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2.6 Determination of Carbapenem Resistant Enterobacteriaceae (CRE) Isolates 
The Kirby-Bauer method of antibiotic susceptibility testing was used to determine the susceptibility of the isolates 
to carbapenems (ertapenem, imipenem, meropenem). Etest system (bioMérieux, France) was also used to 
determine the minimum inhibition concentration (MIC) of the carbapenems. The therapeutic significance of the 
zones of inhibition and MICs was based on the Clinical and Laboratory Standards Institute (CLSI) breakpoints. 
Bacterial isolates that were resistant to the carbapenems were considered carbapenem resistant enterobacteriaceae 
(CRE) isolates. 
 
2.7 Subculturing of Carbapenem Resistant Enterobacteriaceae (CRE) Isolates 
The test organism was subcultured onto Mueller Hinton agar plate and was incubated for 24 hours to obtain a pure 
culture and to ascertain the viability of the organism. At least four colonies from the pure culture were transfer 
into sterile peptone water using an inoculation needle and adjusted to turbidity equivalent to 0.5 McFarland 
Standard. 
 
2.8 Antimicrobial Susceptibility Testing Using Agar Well-Diffusion Method 
Antimicrobial activity of the plant extracts was assessed using the agar- well diffusion method. A 3ml inoculum 
was prepared in peptone water and adjusted to 0.5 McFarland and uniformly spread on the MHA plate using the 
glass spreader. Wells (6mm diameter) were created in the plate using cork borer and 20µl of the plant extract 
concentrations (200 mg/ml – 12.5 mg/ml) were pipetted into the wells at their respective concentration. Amikacin 
(30µg/ml) and colistin (10µg/ml) disks were used as positive controls and 5% v/v DMSO and sterile distilled water 
(SDW) were used as the negative controls. They were allowed to diffuse at room temperature for 30 minutes and 
the plates were then incubated at 37°C for 24 hours.  All experiments were carried out in triplicate. 
After incubation, the diameter zone of inhibition (DZI) were measured and expressed in millimeters. DZI < 7mm 
was considered inactive; 7-10 mm partially active; 11-16 active and > 16 very active as described by Junior and 
Zanil (2000).  
 
2.9 Determination of Minimum Inhibition Concentration (MIC) 
Hundred microlitres (100µl) of ethanol extract of the active plants were added to 100 µl of 5% DMSO in the first 
well of the 96-well microplate and mixed well with a micropipette; 100 µl of this dilution was transferred to the 
next well in the column. This two-fold serial dilution was continued to obtain dilutions ranging from101 to 1010 
with the aid of a micropipette. The final volume in each well was 100 μl. Solutions of a reference antibiotic 
amikacin (30µg/ml) and colistin (10 µg/ml) were also serially diluted in different columns of the microplate as a 
positive control. The wells were inoculated with 5μl of microbial suspension of turbidity equivalent to 0.5 
McFarland and incubated at 37ºC for 24 hours. After incubation, 40µl of 0.2mg/ml INT (p-Iodonitrotetrazolium 
violet) dissolved in sterile distilled water was added to each of the wells. The microplates were examined after 
additional 30 to 120 minutes of incubation.  Bacterial growth was indicated by a red colour of INT reduced to the 
formazan. The lowest concentration at which a decreased in the red colour is apparent compared to the next dilution 
was taken as the MIC value.  
 
2.10 Determination of Minimum Bactericidal Concentration (MBC)  
The MBC values were deduced from those wells with lowest concentrations at which no growth took place after 
culture for 24 hours of incubation. A small sample from each of those wells was transferred to fresh nutrient agar 
plates and was incubated overnight at 37ºC and plates were examined for the presence or absence of living 
organisms. Plates with no microbial growth were regarded as the minimum bactericidal concentrations. 
 
2.11 Phytochemical Screening 
Phytochemical screening methods described by Fong et al., (1977) and Ciulei (1982) were used to screen the 
various extracts for the presence of saponins, reducing compounds, polyuronides, phenolic compounds, alkaloids, 
triterpenes, phytosterols, flavonoids and anthracenosides.  
 
3.0 Results 
3.1 Susceptibility of Carbapenem-Resistant Enterobacteriaceae against Ethanolic Extract of Alchornea 
cordifolia   
The ethanolic extract of Christmas bush leaves varied zones of inhibition as shown in Table 1: 
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Table 1: Susceptibility of carbapenem-resistant Enterobacteriaceae to ethanolic extract of Alchornea cordifolia  
Standards                             Diameter of zones of inhibition (mm) 
Amikacin 
(30 µg/ml) 
Colistin 
(10µg/m) 
SDW/ 
DMSO 
 
 
200 mg/ml 100 mg/ml 50 mg/m 25 mg/m 12.5 mg/ml  
22.0 ± 0.5 17.0 ± 0.5 0.0 
 
16.3 ± 1.0 13.7 ± 0.5 11.9 ± 1.3 8.5 ± 2.5 0.0 ± 0.0     
             
Values are mean inhibition zone (mm) ± S.D of three replicates 
 
3.2 Minimum Inhibition Concentration (MIC) and Minimum Bactericidal Concentration (MBC) 
The minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) shown in Table 2 
were determined using the 96 well microplate. 
Table 2: MIC and MBC of ethanol leaves extracts of Alchornea cordifolia against CREs 
Plant extract     MIC (mg/ml) MBC (mg/ml) 
Alchornea cordifolia 3.13 3.13 
 
3.3 Phytochemical Constituents 
The phytochemical constituents of the A. cordifolia leaves extract were saponins, phenolic compounds, reducing 
sugars, polyuronoids and flavonoids as shown in Table 3. Previous work by Siwe Noundou et al., (2016) had 
identified the antibacterial compounds in A. cordifolia leaves and elucidated their chemical structure. 
Table 3: Phytochemical constituents of A. cordifolia leaves 
Phytochemical A. cordifolia 
Saponins + 
Phenolic compounds - 
Reducing sugars + 
Polyuronoids - 
Alkaloids - 
Triterpenes - 
Phytosterols - 
Flavonoids + 
Anthracenosides - 
            Detected = (+); Not Detected = (-) 
 
4.0 Discussion 
The varied concentrations (50 mg/ml – 200 mg/ml) of the Christmas bush leaves extracts, which were used against 
the CRE strain employing the agar diffusion method, revealed significant antibacterial activity against the test 
organism as shown in Table 2. Furthermore, ethanolic extracts of the shrubs’ leaves had MIC and MBC of 3.13 
mg/ml against CREs.  
This may be because Alchornea cordifolia leaves possess phytochemicals such as saponins, reducing sugars 
and flavonoids (George et al., 2010). Flavonoids have been known to possess the antibacterial effect. According 
to Siwe Noundou et al., (2016) antibacterial compounds such as stigmasterol, stigmasta-4,22-dien-3-one, friedelin, 
friedelane-3-one-28-al, 3-O-acetyl-aleuritolic acid , 3-O-acetyl-erythrodiol and methyl-3,4,5-trihydroxybenzoate 
(methyl gallate)were isolated from Christmas bush. It could be that the extract used in this study may contain these 
compounds since they fall under flavonoids and the phytochemical screening of the test plant revealed that it 
contains flavonoids as shown in Table 1. There might be other phytochemicals that were not determined in this 
study, which may be responsible for the antibacterial activity of the A. cordifolia leaves.  
The activity of the standards (amikacin and colistin) used in this study as positive control corresponds with 
the results of Hackman et al., (2017) although amikacin (30 µg/ml) used in this study shows a higher diameter 
zone of inhibition. According to Junior and Zanil (2000) diameter zone of inhibition of 11-16 is considered active 
and >16 is considered very active. From the results, concentrations of the test plant ranging from 50 mg/ml – 200 
mg/ml showed active diameter zone of inhibition. From Table 2, A. cordifolia had an MIC of 3.13 mg/ml with 
MBC of 3,13 mg/ml with percentage inhibition index of 2.94. This showed that the appropriate concentration of 
the ethanolic extract of Christmas bush leaves is able to inhibit the growth of the CREs. 
 
5.0 Conclusions 
The hypothesis for this study proved positive since the shrub under study showed activity against CREs. Ethanolic 
extracts of A. cordifolia leaves is proving to be efficacious against multi-drug resistant CRE, which is a major 
cause of serious systemic infections. Phytochemical screening of the leaves showed that it possesses flavonoids, 
saponins and reducing sugars, which is responsible for the antibacterial efficacy of the leaves extracts. This offers 
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hope for the development of effective antibiotics for the treatment of multi-drug resistant systemic infections. 
Therefore, there is the need to determine the toxicological effect and perform clinical trials of the active 
antimicrobial compounds isolated in the leaves extracts of A. cordifolia.  
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